Therefore, further population case-control studies among Colombians with different African ancestry proportions, seeking differences in the expression levels of IL-1 beta and its targets (such as COX-2 and PGE2) in colorectal tissues and plasma samples will help prove their utility as susceptibility markers for the risk of CRC in the general population. This evidence concerns the gene IL1B and colorectal carcinoma.